Global HEOR Director: Payer Access & HTA Strategy in Zürich

Denali Therapeutics invites you to lead our global HEOR strategy for ex-US markets, ensuring alignment with market access, regulatory and launch objectives. You will own the core global health economic model, oversee cost-effectiveness analyses, and guide real-world evidence to support HTA submissions in Europe and beyond.You will collaborate with International Market Access, Regulatory, Biometrics, Clinical Development, and Commercial teams, and mentor colleagues as the function scales in a #J-18808-Ljbffr